desonide

DRUG3 trials

Sponsors

Centre Hospitalier Universitaire De Nantes, Universidad Autonoma de San Luis Potosí, EMS

Conditions

HyperpigmentationPsoriasisatopic dermatitis

Phase 4

Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation

CompletedNCT01542138

Universidad Autonoma de San Luis PotosíHyperpigmentation

Start: 2011-07-31End: 2012-11-30Updated: 2012-11-29

Proton Pump Inhibitors Use in Patients With Psoriasis

WithdrawnNCT02624544

Start: 2016-01-31End: 2016-12-31Updated: 2022-08-05

Dupilumab step-down strategy to maintain remission in adult and adolescents patients with atopic dermatitis: a non-inferiority randomized trial

Active, not recruitingCTIS2022-501179-23-00

Centre Hospitalier Universitaire De Nantesatopic dermatitis

Start: 2023-03-08Target: 256Updated: 2025-07-11

Related Papers

Dupilumab step-down strategy to maintain remission in adult and adolescent patients with atopic dermatitis: study protocol for a non-inferiority randomized trial (MADULO).

2025-12-05